Cargando…

P365: SEQUENTIAL BLINATUMOMAB WITH REDUCED INTENSITY CHEMOTHERAPY FOR OLDER ADULTS WITH NEWLY DIAGNOSED PH- B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA – FINAL RESULTS OF THE ALLG ALL08 STUDY

Detalles Bibliográficos
Autores principales:	Fleming, Shaun, Reynolds, John, Bajel, Ashish, Venn, Nicola, Kwan, John, Moore, John, Yeung, David, Pati, Nalini, Leahy, Michael, Kollipara, Sushma, Verner, Emma, Berkahn, Leanne, Sutton, Rosemary, Wei, Andrew, Greenwood, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428405/ http://dx.doi.org/10.1097/01.HS9.0000968372.81147.9d

Ejemplares similares

Cases from the Practice of Dr. Hansen: Allg. Hom. Zeitung 23, ’90
Publicado: (1890)

Advancements in Therapy for Acute Lymphoblastic Leukemia: Blinatumomab
por: Hladnik,1, Lindsay, et al.
Publicado: (2016)

Recent advances on blinatumomab for acute lymphoblastic leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019)

An Unnoticed Symptom of Ipecacuanha, Clinically Verified by Dr. Mossa: Allg. Hom. Zeitung, No. 3, 1889
Publicado: (1889)

Blinatumomab-associated vasculitis
por: Liau, MeiQi May, et al.
Publicado: (2017)

Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia
por: Wei, Andrew H., et al.
Publicado: (2021)

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)
por: Kalff, Anna, et al.
Publicado: (2021)

Statistics of Small-Pox: Remarks on a Report of Dr. L. J. Keller, in the “Allg. Wiener Med. Zeitung”
por: Gradle, H.
Publicado: (1874)

MOS study guide for Microsoft Office 365
por: Pierce, John
Publicado: (2012)

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab
por: So, Wonhee, et al.
Publicado: (2018)

Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies
por: Clements, John David, et al.
Publicado: (2019)

The “Correction” of Professor Dr. G. Jaeger from the Hahnemannian Standpoint: In the Allg. Hom. Zeitung, Vol. 125, P. 157
por: Fincke, B.
Publicado: (1893)

Exposure–response analysis of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukaemia and comparison with standard of care chemotherapy
por: Kuchimanchi, Mita, et al.
Publicado: (2019)

Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemia
por: Le Jeune, Caroline, et al.
Publicado: (2016)

Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
por: Lee, Kum Ja, et al.
Publicado: (2016)

365 vidas minadas = 365 mined lives
por: Sánchez, Gervasio 1959-
Publicado: (2007)

Blinatumomab in Relapsed/Refractory Burkitt Lymphoma
por: Bohler, Jeanne, et al.
Publicado: (2022)

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia
por: Portell, Craig A, et al.
Publicado: (2013)

Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia
por: Ribera, Josep-Maria, et al.
Publicado: (2015)

Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab
por: Litzow, Mark R
Publicado: (2014)

Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
por: Verneris, Michael R., et al.
Publicado: (2021)

Positioning blinatumomab in the frontline of adult B-cell acute lymphoblastic leukemia treatment
por: Pourhassan, Hoda, et al.
Publicado: (2023)

Office 365 essentials: get up and running with the fundamentals of Office 365
por: Árias Silva, Nuno
Publicado: (2018)

PowerShell for Office 365: automate Office 365 administrative tasks
por: Machado, Martín, et al.
Publicado: (2017)

Office 365 For Dummies
por: Withee, Ken, et al.
Publicado: (2012)

Office 365 for dummies
por: Withee, Rosemarie, et al.
Publicado: (2019)

Blinatumomab in Ph+ B-ALL: present and perspectives
por: Papayannidis, Cristina, et al.
Publicado: (2017)

Cytokine Release Syndrome Following Blinatumomab Therapy
por: Ojemolon, Pius E, et al.
Publicado: (2022)

PB2176: AN AUSTRALIAN/NEW ZEALAND RANDOMIZED TRIAL OF POST-TRANSPLANT CYCLOPHOSPHAMIDE IN MATCHED RELATED PERIPHERAL BLOOD STEM CELL TRANSPLANTS FOR ACUTE LEUKAEMIA OR MYELODYSPLASIA – ALLG BM12
por: Curtis, D., et al.
Publicado: (2022)

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
por: Gökbuget, N, et al.
Publicado: (2016)

Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date
por: Hathaway, Lindsey, et al.
Publicado: (2018)

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab
por: Queudeville, Manon, et al.
Publicado: (2017)

Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
por: Topp, Max S., et al.
Publicado: (2020)

Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children
por: Xie, Jiao, et al.
Publicado: (2023)

P1176: RITUXIMAB IN PRIMARY CNS LYMPHOMA – LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY
por: Doorduijn, J., et al.
Publicado: (2022)

Programming Microsoft Office 365: covers Microsoft Graph, Office 365 applications, SharePoint add-ins, Office 365 Groups, and more
por: Pialorsi, Paolo
Publicado: (2016)

Dynamics 365 Essentials: Getting Started with Dynamics 365 Apps in the Common Data Service
por: Critchley, Sarah
Publicado: (2020)

365 + 1 cócteles : ars combinatoria
por: Delgado, Carlos
Publicado: (1983)

Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies
por: Jacoby, Elad
Publicado: (2019)

Microsoft dynamics 365 for dummies
por: Bellu, Renato
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mm2r8a430ef91iesouqv6l1vsr